Ibuprom Zatoki Sprint (Pseudoephedrine Hydrochloride, Ibuprofen)

Ibuprofen, one of the active ingredients, blocks cyclo‑oxygenase enzymes (COX‑1 and COX‑2), which reduces the formation of prostaglandins—chemicals that cause pain, inflammation, and fever. This action provides analgesic, anti‑inflammatory, and antipyretic effects.

The appropriate dose of Ibuprom Zatoki Sprint is determined by the prescribing healthcare professional based on the patient’s condition, age, weight, and other clinical factors. Patients should follow the prescriber’s instructions and not exceed the recommended amount.

Use of Ibuprom Zatoki Sprint during pregnancy is generally avoided, especially in the third trimester, due to potential risks to the fetus. Breastfeeding mothers should consult their physician, as ibuprofen and pseudoephedrine can pass into breast milk and may affect the infant.

To order, submit an enquiry on the product page at gnhindia.com specifying the required quantity. GNH India works with hospitals, pharmacies, and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details, and any necessary import documentation.

Compared with single‑ingredient NSAIDs, Ibuprom Zatoki Sprint adds a decongestant, making it useful when pain co‑exists with nasal congestion. Unlike pure decongestant tablets, it also offers analgesic and antipyretic benefits, providing a broader symptom‑relief profile for cold‑related discomfort.

Ibuprom Zatoki Sprint should be stored at ambient temperature, below 25 °C, in its original packaging. Keep the container tightly closed, protect it from moisture and direct sunlight, and keep it out of reach of children.

The product is taken orally with a full glass of water. It may be taken with or without food, but taking it with food can reduce stomach irritation. Swallow the tablet whole; do not crush or chew it.

Serious risks include gastrointestinal bleeding or ulceration, severe allergic reactions such as anaphylaxis, significant elevation of blood pressure, renal impairment, and rare liver injury. Patients should seek immediate medical attention if they experience symptoms like vomiting blood, severe rash, or sudden swelling.

Individuals with known hypersensitivity to ibuprofen, pseudoephedrine, or any component of the formulation should avoid it. It is also contraindicated in patients with active peptic ulcer disease, severe uncontrolled hypertension, recent coronary artery bypass grafting, or those taking monoamine oxidase inhibitors.